United Therapeutics (Germany) Top Insiders

UTH Stock  EUR 277.30  0.60  0.22%   
United Therapeutics employs about 965 people. The company is managed by 10 executives with a total tenure of roughly 2252 years, averaging almost 225.0 years of service per executive, having 96.5 employees per reported executive. Examination of United Therapeutics' management performance can provide insight into the company performance.
James Edgemond  Insider
CFO Treasurer
JD MBA  Insider
Chairman Founder
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in United Stock please use our How to Invest in United Therapeutics guide.

United Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of 0.1102 % which means that it generated a profit of $0.1102 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1661 %, meaning that it generated $0.1661 on every $100 dollars invested by stockholders. United Therapeutics' management efficiency ratios could be used to measure how well United Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

United Therapeutics Workforce Comparison

United Therapeutics is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 311,076. United Therapeutics adds roughly 965 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.38 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.51 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.51.

United Therapeutics Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. United Therapeutics Price Series Summation is a cross summation of United Therapeutics price series and its benchmark/peer.

United Therapeutics Notable Stakeholders

An United Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as United Therapeutics often face trade-offs trying to please all of them. United Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting United Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About United Therapeutics Management Performance

The success or failure of an entity such as United Therapeutics often depends on how effective the management is. United Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of United management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the United management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening diseases primarily in the United States and Europe. United Therapeutics Corporation was founded in 1996 and is headquartered in Silver Spring, Maryland. UTD THERAP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 860 people.

United Therapeutics Workforce Analysis

Traditionally, organizations such as United Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare United Therapeutics within its industry.

United Therapeutics Manpower Efficiency

Return on United Therapeutics Manpower

Revenue Per Employee2M
Revenue Per Executive193.6M
Net Income Per Employee753.7K
Net Income Per Executive72.7M

Complementary Tools for United Stock analysis

When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stocks Directory
Find actively traded stocks across global markets